An open, dose-ranging, phase II trial of chlorproguanil/dapsone with three doses of artesunate for the treatment of acute uncomplicated Plasmodium Falciparum malaria
Wootton, D; Opara, H; Nyirenda, M; Blencoe, H; Kanjala, M; Baldeh, I; Woessners, M; Neate, C; Duparc, S; Kirby, P; +4 more...Milligan, P; Molyneux, M; Dunyo, S; and Winstanley, P
(2005)
An open, dose-ranging, phase II trial of chlorproguanil/dapsone with three doses of artesunate for the treatment of acute uncomplicated Plasmodium Falciparum malaria.
[Conference or Workshop Item]
https://researchonline.lshtm.ac.uk/id/eprint/6470
| Item Type | Conference or Workshop Item (UNSPECIFIED) |
|---|---|
| ISI | 202990001093 |
| Date Deposited | 17 Oct 2011 15:57 |